ARCHIVES

Toxic Substance Act Would Affect Cancer Program

This article is from The Cancer Letter archive.

Vol. 01 No. 12 | March 21, 1975

Download PDF Visit The Full Archive

Related Articles

In Brief: Duke’s Gary Lyman to Co-Direct Fred Hutch Outcomes Research

January 10, 2014

Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities

July 28, 2000

Pittsburgh Investigates Use of Resources in Anonymous Mailing To Researchers

April 29, 1994

NCI-Approved Clinical Trials

September 29, 2006

Coalition Demands Role In Deciding spending will Target Healy, Broder, Chabner

October 16, 1992

Broder Issues Clinical Alert on 5-FU Levamisle Survival Advantage for Dukes C Colon Cancer

October 6, 1989